110 results on '"Pumpo R"'
Search Results
2. BOC.01.9: ADHERENCE TO QUALITY PERFORMANCE MEASURES FOR ENDOSCOPY IN IBD: A NATIONWIDE ITALIAN SURVEY
3. The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study
4. Derivation and validation of Re.Co.De death score risk in patients with acute nonvariceal upper GI bleeding
5. The "Hub and Spoke" model has no effect on mortality in acute upper gastrointestinal bleeding: A prospective multicenter cohort study
6. T01.01.7 THE USE OF A SPECIALIZED BLEEDING-MANAGEMENT TEAM HAD NO IMPACT ON MORTALITY FOR ACUTE UPPER GASTROINTESTINAL BLEEDING: AN ITALIAN PROSPECTIVE MULTICENTER COHORT STUDY
7. OC.10.1 THE USE OF PRE-ENDOSCOPIC INTRAVENOUS PROTON PUMP INHIBITORS (PPIS) HAD NO IMPACT ON CLINICAL OUTCOMES IN ACUTE UPPER GASTROINTESTINAL BLEEDING: A PROSPECTIVE MULTICENTER ITALIAN COHORT STUDY
8. HUMAN NICOTINAMIDE N-METHYLTRANSFERASE EXPRESSION IN NORMAL LIVER
9. OC.11.5 TRIGGER AND TARGET TRANSFUSION STRATEGY IN PATIENTS WITH NON-VARICEAL ACUTE UPPER GASTROINTESTINAL BLEEDING (NV-AUGIB): A PROSPECTIVE MULTICENTRE OBSERVATIONAL STUDY
10. OC.14.2 PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY
11. P84 A case of short stature: a milder phenotypic spectrum of noonan syndrome?
12. P85 A case of gh deficiency in a patient with joubert syndrome
13. P.10.8: Mortality from Acute Upper Gastrointestinal Bleeding (UGIB): The Role of the Organizational and Health Care Course: A Prospective Multicentre Observational Study in Italy
14. P.10.1: Transfusion Strategy and Death Risk in Patients with Acute Non-Variceal Upper Gastro Intestinal Bleeding (NV-UGIB) in Italy: A Prospective Multicenter Observational Study
15. P.10.3: Mortality in Upper Gastrointestinal Bleeding in Italy: Data from National Survey
16. P.10.10: Mortality Causes from Acute Upper Gastrointestinal Bleeding: A Prospective Multicentre Observational Study
17. P.10.9: Outpatient Management of Patients with Glasgow-Blatchford Bleeding Score Low-Risk Upper-Gastrointestinal Hemorrhage: A Multicenter Validation Study in Italy
18. Gastrointestinal hormones in acute viral hepatitis
19. P.15.8 POOR OUTCOME FROM ACUTE UPPER GASTROINTESTINAL BLEEDING IN PATIENTS WITH LIVER CIRRHOSIS: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY
20. P.15.9 TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY
21. P.15.3 INCREASED PERFORMANCE OF AN UPDATED ROCKALL SCORE IN ACUTE NON VARICEAL UPPER GASTRO INTESTINAL BLEEDING: A PROSPECTIVE MULTICENTRE ITALIAN STUDY
22. Il test di sazietà precoce con un pasto liquido e lo svuotamento gastrico nella dispepsia funzionale
23. Early satiety test by liquid meal: role of administration rate of meal
24. Liver nicotinamide methylation: N-methylnicotinamide-transferase expression in cirrhosis
25. Relationship between of clinical of hepatocellular carcinoma and serum transforming growth factor
26. Human liver Nicotinamide N-Methyltransferase: gene ena protein expression in patients with liver disease
27. Morfologia manometrica della piccola ernia iatale e reflusso gastroesofageo
28. Analysis of the relationship between functional dyspepsia symptoms and gastric emptying
29. Human nicotinamide N-methyltransferase expression in normal liver
30. Early satiety and gastric emptying in dyspepsia
31. Esophageal manometry in asymptomatic hiatal hernia
32. Il tempo di transito intestinale riflessioni metodologiche
33. Escrezione urinaria dei metaboliti della nicotinamide nella cirrosi epatica
34. Hexachlorobenzene experimental intoxication in the rat: effects on body growth and on liver trace elements and calcium
35. Espressione dell’mRNA della nicotinamide metiltransferasi nell’epatocarcinoma e nel tessuto cirrotico circostante
36. Methylated metabolites of nicotinamide in human liver cirrhosis
37. Colonic transit and symptoms in patients complaining of constipation
38. Urinary excretion of nicotinamide metabolites in liver cirrhosis
39. La metilazione della nicotinamide come espressione di danno epatico. Studi clinici sperimentali
40. S-Adenosyl-L-Methionine (SAMe)-dependent Nicotinamide methylation: a marker of Hepatic damage
41. Nicotinamide methylation and hepatic energy reserve
42. Resolution of 5-hydroxymethyl-2-oxazolidinone by preferential crystallization[ 1 ] and investigations on the nature of the racemates of some 2-oxazolidinone derivatives
43. Tests to evaluate the liver energy reserve and hepatocyto-protective effect of drugs in man
44. Nicotinamide methylation: a function test in liver damage
45. Is N-methylnicotinamide production a marker of hepatic damage?
46. Nicotinamide methylation in human liver disease
47. Nicotinamide methylation in human liver cirrhosis
48. The Metabolism of Nicotinamide in Human Liver Cirrhosis. A Study on N-Methylnicotinamide and 2-Pyridone-2-Carboxamide Production
49. Liver nicotinamide methylation:nicotinamide N-methyltransferase expression in cirrhosis
50. Hepatic expression of nicotinamide methyltransferase in man
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.